Total Payments
$73,460
2022 Payments
$230.50
Companies
49
Transactions
1,054
Medicare Patients
2,968
Medicare Billing
$236,311
Payment Breakdown by Category
Other$49,316 (67.1%)
Food & Beverage$19,554 (26.6%)
Travel$4,409 (6.0%)
Education$181.78 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,316 | 25 | 67.1% |
| Food and Beverage | $19,554 | 995 | 26.6% |
| Travel and Lodging | $4,409 | 22 | 6.0% |
| Education | $181.78 | 12 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $57,464 | 171 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $5,634 | 172 | $0 (2022) |
| ABBVIE INC. | $1,137 | 79 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,133 | 66 | $0 (2022) |
| PFIZER INC. | $894.36 | 92 | $0 (2021) |
| GlaxoSmithKline, LLC. | $879.54 | 72 | $0 (2022) |
| Amgen Inc. | $817.46 | 48 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $589.41 | 36 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $387.23 | 32 | $0 (2021) |
| Lilly USA, LLC | $375.30 | 32 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $230.50 | 13 | Janssen Pharmaceuticals, Inc ($48.81) |
| 2021 | $3,190 | 198 | AbbVie Inc. ($432.68) |
| 2020 | $5,699 | 157 | Novo Nordisk Inc ($3,171) |
| 2019 | $15,619 | 198 | Novo Nordisk Inc ($11,309) |
| 2018 | $26,576 | 246 | Novo Nordisk Inc ($23,176) |
| 2017 | $22,145 | 242 | Novo Nordisk Inc ($19,527) |
All Payment Transactions
1,054 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2022 | Almatica Pharma LLC | LOREEV XR (Drug), GRALISE | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/04/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/02/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 01/26/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2022 | EISAI INC. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $12.92 | General |
| Category: Neurology | ||||||
| 01/24/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/05/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular | ||||||
| 12/16/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: VACCINES | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Gastroenterology | ||||||
| 12/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 12/08/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Diabetes | ||||||
| 12/07/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/07/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 109 | 109 | $16,522 | $3,023 |
| 2021 | 16 | 1,301 | 2,098 | $322,709 | $114,463 |
| 2020 | 17 | 1,558 | 2,573 | $382,739 | $118,825 |
Total Patients
2,968
Total Services
4,780
Medicare Billing
$236,311
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 47 | $11,280 | $2,090 | 18.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 17 | $1,748 | $401.84 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,860 | $343.49 | 18.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 16 | 16 | $784.00 | $99.68 | 12.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 17 | 17 | $850.00 | $88.06 | 10.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 260 | 640 | $153,600 | $54,172 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 160 | 160 | $38,400 | $20,749 | 54.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 248 | $38,440 | $15,831 | 41.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 46 | 233 | $23,964 | $6,758 | 28.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 17 | $9,911 | $3,705 | 37.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $4,543 | $1,813 | 39.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 17 | 17 | $12,410 | $1,701 | 13.7% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 80 | 80 | $4,800 | $1,621 | 33.8% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 18 | 48 | $4,080 | $1,404 | 34.4% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 176 | 222 | $10,878 | $1,383 | 12.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,914 | $1,361 | 71.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 79 | 79 | $3,950 | $1,284 | 32.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 68 | 68 | $3,740 | $1,230 | 32.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 176 | 221 | $11,050 | $1,145 | 10.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $525.00 | $243.15 | 46.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 28 | $504.00 | $63.00 | 12.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 281 | 735 | $171,648 | $50,297 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 189 | 189 | $45,360 | $21,303 | 47.0% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 51 | 411 | $42,271 | $12,716 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 207 | $31,740 | $10,797 | 34.0% |
About Dr. Paul Chang, MD
Dr. Paul Chang, MD is a Internal Medicine healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790797280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Chang, MD has received a total of $73,460 in payments from pharmaceutical and medical device companies, with $230.50 received in 2022. These payments were reported across 1,054 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,316).
As a Medicare-enrolled provider, Chang has provided services to 2,968 Medicare beneficiaries, totaling 4,780 services with total Medicare billing of $236,311. Data is available for 3 years (2020–2022), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Asheville, NC
- Active Since 08/12/2006
- Last Updated 09/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790797280
Products in Payments
- Tresiba (Drug) $24,908
- Ozempic (Drug) $8,406
- Victoza (Drug) $7,352
- XARELTO (Drug) $3,789
- Xultophy 100/3.6 (Drug) $2,569
- INVOKANA (Drug) $1,845
- ELIQUIS (Drug) $477.61
- FARXIGA (Drug) $470.18
- VRAYLAR (Drug) $436.47
- TRELEGY ELLIPTA (Drug) $428.84
- Aimovig (Biological) $372.41
- CHANTIX (Drug) $352.29
- XIFAXAN (Drug) $312.69
- RYBELSUS (Drug) $296.03
- ENTRESTO (Drug) $290.75
- Kerendia (Drug) $285.02
- TRULICITY (Drug) $245.45
- ANORO (Drug) $243.00
- Synthroid (Drug) $230.14
- SYNTHROID (Drug) $210.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Asheville
Dr. John Rhyner, Md, MD
Internal Medicine — Payments: $246,852
Internal Medicine $246,852
Christopher Patterson, Md, MD
Internal Medicine — Payments: $119,213
Internal Medicine $119,213
Dr. Christopher Komanski, M.d, M.D
Internal Medicine — Payments: $111,660
Internal Medicine $111,660
Dr. Zachary Hale, M.d, M.D
Internal Medicine — Payments: $52,123
Internal Medicine $52,123
John Brandt, M.d, M.D
Internal Medicine — Payments: $51,750
Internal Medicine $51,750
Dr. Brett Izzo, M.d, M.D
Internal Medicine — Payments: $18,038
Internal Medicine $18,038